STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
DelistingApr 29, 2026, 06:13 AM

PRTC to Delist ADSs from Nasdaq, Concentrate Trading on LSE

AI Summary

PureTech Health plc announced its intention to voluntarily delist its American Depositary Shares (ADSs) from Nasdaq. This strategic move aims to concentrate the trading of its shares on the London Stock Exchange (LSE).

Key Highlights

  • PureTech Health plc intends to voluntarily delist its American Depositary Shares (ADSs) from Nasdaq.
  • The company plans to concentrate the trading of its shares on the London Stock Exchange (LSE).
PRTC
Biotechnology: Pharmaceutical Preparations
PureTech Health plc

Price Impact